Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2019 16:15 ET | Source: iBio, Inc.

iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage

NEW YORK, Sept. 17, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”) today announced that it has entered into the initial Statement of Work (“SOW1”) under its...
August 26, 2019 17:30 ET | Source: iBio, Inc.

iBio and CC-Pharming Expand Business Collaboration in China

NEW YORK, Aug. 26, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has expanded the scope of its business venture with CC-Pharming Ltd. by granting it an exclusive,...
August 19, 2019 16:35 ET | Source: iBio, Inc.

iBio Inks 3D Bioprinting Agreement

NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced that it has entered into a Master Services Agreement (“MSA”) with Lung Biotechnology PBC, a subsidiary of...
June 19, 2019 08:00 ET | Source: iBio, Inc.

iBio Announces First Agreement for Fill-Finish Services

NEW YORK, June 19, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”) today announced the activation of its new cGMP sterile fill-finish services operation via the...
June 03, 2019 08:00 ET | Source: iBio, Inc.

iBio Launches New Sterile Fill-Finish Services

NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”) today introduced new cGMP sterile fill-finish capabilities for pharmaceutical products,...
April 01, 2019 08:30 ET | Source: iBio, Inc.

iBio Announces Appointment of Thomas F. Isett to Board of Directors

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a biologics contract manufacturer and product developer with proprietary, “green” technologies for biopharmaceutical...
December 14, 2018 08:00 ET | Source: iBio, Inc.

iBio Provides Status Update on its Continuing Litigation Against Fraunhofer

NEW YORK, Dec. 14, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, announced today that the Second Complaint it filed in iBio’s litigation...
December 03, 2018 08:00 ET | Source: iBio, Inc.

iBio to Present at Brazilian Ministry of Health’s Plant-Made Pharmaceutical Meeting

NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, today announced that it will present at the Plant-Based Technology...
October 02, 2018 08:00 ET | Source: iBio, Inc.

iBio and CC-Pharming Hold First Design and Strategy Meeting

NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the beginning of a four-day design and strategic planning meeting with executives and technical experts...
August 22, 2018 16:10 ET | Source: iBio, Inc.

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that NYSE Regulation has accepted the Company’s plan to regain compliance with...